AXOVANT GENE THERAPIES LTD

CUSIP: G0750W203 Class: COM

DAFNA Capital Management LLC's Holding History (CIK: 0001389933)

Note: Option positions (PUT/CALL) are excluded.

Q3 2020
Shares 171,083 Value ($000) $790 Avg Close — Range —
Q2 2020
Shares 1,005,391 Value ($000) $2,835 Avg Close — Range —
Q1 2020
Shares 1,021,566 Value ($000) $2,493 Avg Close — Range —